Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine.
about
Vaccines for Pseudomonas aeruginosa: a long and winding roadMicrobial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepaciaLung infections associated with cystic fibrosis.Antibiofilm activity of an exopolysaccharide from marine bacterium Vibrio sp. QY101.Naturally acquired antibodies against four Enterococcus faecalis capsular polysaccharides in healthy human sera.Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci.Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine.Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice.Overexpression of Brucella putative glycosyltransferase WbkA in B. abortus RB51 leads to production of exopolysaccharide.Rapid adaptation drives invasion of airway donor microbiota by Pseudomonas after lung transplantation.Mesenchymal stem cells for craniofacial tissue regeneration: designing hydrogel delivery vehicles.Recent developments for Pseudomonas vaccines.Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis.Potential targets for next generation anti-microbial glycoconjugate vaccines.
P2860
Q26852817-25FDA7B8-E635-4FFB-9D25-483C4AA36708Q29615286-B31B38DF-FC16-4D97-802F-662CA5D809A1Q30080000-224FC4BD-B244-4371-B3C0-4075A3C92610Q33872164-0470F000-BB05-4CCC-8A30-B7CE5CD15838Q33910719-8E65AB17-8F9C-4E90-AABB-544BDEA1C7A5Q34000731-DEBD0C92-3703-44DC-9970-1D81438C5DD3Q34007780-F282BE17-689A-4C2E-8468-745F035B9C68Q35106317-F0D5EC87-EED4-4C69-B068-5249F613F9DFQ35139384-CDDF4F13-65A0-4796-A55B-88897F365CA2Q35773649-BDFA2210-416F-4E18-A314-17A7B38FC8B3Q37589273-D200EE16-5C9C-49C0-9D60-6EFA58D277F0Q37592909-60B95FD2-56DF-45D9-A302-79EDB0DB8EC7Q37937369-316DCBBE-5E61-4226-AF08-52888923FACCQ39519011-4A3161F4-B70B-4FBC-A48B-B714CCFE26BEQ53701548-5A6715AE-BA9A-4BF1-9716-A05A09D47E04
P2860
Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine.
description
1994 nî lūn-bûn
@nan
1994 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Human immune response to Pseud ...... saccharide (alginate) vaccine.
@ast
Human immune response to Pseud ...... saccharide (alginate) vaccine.
@en
Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide
@nl
type
label
Human immune response to Pseud ...... saccharide (alginate) vaccine.
@ast
Human immune response to Pseud ...... saccharide (alginate) vaccine.
@en
Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide
@nl
prefLabel
Human immune response to Pseud ...... saccharide (alginate) vaccine.
@ast
Human immune response to Pseud ...... saccharide (alginate) vaccine.
@en
Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide
@nl
P2093
P2860
P1476
Human immune response to Pseud ...... ysaccharide (alginate) vaccine
@en
P2093
D DesJardin
H C Miller
M O Thornton
S A Fuller
S E Bennett
W S Harkonen
P2860
P304
P407
P50
P577
1994-09-01T00:00:00Z